Document is current
Any future updates will be listed below
-
Authors
Hasegawa, Hiro http://orcid.org/0000-0002-2143-6503
Takeshita, Nobuyoshi http://orcid.org/0000-0001-8089-7433
Hyon, Woogi
Hyon, Suong-Hyu
Ito, Masaaki http://orcid.org/0000-0002-1101-2707
- License Information
-
More Information
Article History
Received: 11 May 2022
Accepted: 4 May 2023
First Online: 11 May 2023
Declarations
:
: HH, NT, and MI received experimental animals and a novel external reinforcement device for gastrointestinal anastomosis from BMG Incorporated, Kyoto, Japan. National cancer center, WH and SHH have a patent of the novel external reinforcement device. WH and SHH are employees of BMG Incorporated, Kyoto, Japan. WH and SHH had no role in the analysis or interpretation of the data. Conflicts of interest are properly managed in accordance with the regulations of each institution.
: The study protocol was approved by the Committee for Ethics of Animal Experimentation of the National Cancer Center (K17–012). The experiment was performed according to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines and the Guidelines for Animal Experiments (Science Council of Japan: Guidelines for Proper Conduct of Animal Experiments, 2006).
: Not applicable.
